Mainz Biomed (NASDAQ:MYNZ) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Mainz Biomed (MYNZ) operate in?

Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Mainz Biomed Stock (NASDAQ: MYNZ) stock price, news, charts, stock research, profile.

Open	$0.34
Close	$0.34
Volume / Avg.	204.25K / 244.23K
Day Range	0.33 - 0.37
52 Wk Range	0.32 - 5.01
Market Cap	$7.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	1.53%
Days to Cover	1.1

Recent News

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens the door to a more personalized and effective treatment as messenger RNA instructs the patient’s cells how to combat diseases like cancer.

Upwallstreet

Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight

On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threatens to undermine confidence the research abilities of the Darmstadt, Germany-based company that is not related to the U.S-based Merck & Co (NYSE: MRK).

Upwallstreet

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Mainz Biomed N.V.

Sector

Health Care

Industry

Biotechnology

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening co...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mainz Biomed (MYNZ) stock?

You can purchase shares of Mainz Biomed (NASDAQ:MYNZ) through any online brokerage.

View our list of the best stock brokerages

Who are Mainz Biomed (MYNZ) competitors?

Other companies in Mainz Biomed’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Addex Therapeutics (NASDAQ:ADXN), Geovax Labs (NASDAQ:GOVX) and NuCana (NASDAQ:NCNA).

What is the target price for Mainz Biomed (MYNZ) stock?

There is no analysis for Mainz Biomed.

What is the forecast for Mainz Biomed (MYNZ) stock?

Mainz Biomed has a consensus price target of $4.67.

Current stock price for Mainz Biomed (MYNZ)?

The stock price for Mainz Biomed (NASDAQ: MYNZ) is $0.3312 last updated July 3, 2024 at 4:55 PM EDT.

Does Mainz Biomed (MYNZ) pay a dividend?

There are no upcoming dividends for Mainz Biomed.

When is Mainz Biomed (NASDAQ:MYNZ) reporting earnings?

Mainz Biomed’s Q2 earnings are confirmed for Tuesday, August 13, 2024.

Is Mainz Biomed (MYNZ) going to split?

There is no upcoming split for Mainz Biomed.

What sector and industry does Mainz Biomed (MYNZ) operate in?

Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Mainz Biomed

Mainz Biomed (MYNZ) Forecast